GGrantIndex
← Search

FINAL-STAGE PRECLINICAL DEVELOPMENT OF A LONG-ACTING, NON-OPIOID PEPTIDOMIMETIC DRUG FOR CHRONIC PAIN

$5,599,963FY2022Defense Health AgencyDOD

Alcamena Stem Cell Therapeutics, Llc, Baltimore MD

Investigators

View source on USAspending →